Nootropic Raw Material Idra-21 Powder CAS 22503-72-6

• Powder: Yes
• Customized: Non-Customized
• Certification: GMP, HSE, ISO 9001, USP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Model NO.: Idra-21
• Product Name: Idra-21
• CAS: 22503-72-6
• Molecular Fomula: C8h9cln2o2s
• Molecular Weight: 232.687
• Appearance: White Powder
• Loss on Drying: Nmt 5%
• Ash: Nmt 5%
• Heavy Metals: Nmt 10ppm
• Water: Nmt 5%
• Boiling Point: 634.1
• Other Name: Idra-21
• Noq: 1kg
• Function: Nootropics
• Assay: 99.0%
• Shelf Life: 2 Years
• Transport Package: 1kg/Bag
• Specification: 25KG/Drum
• Trademark: Source Herb
• Origin: China
• Production Capacity: 100 Mt/Year

Product Description

Nootropic Raw Material Idra-21 powder CAS 22503-72-6

Introduction

 

Product Name	IDRA-21	Appearance	White powder
Molecular Formula	C8H9ClN2O2S	Molecular Weight	232.687
Cas No.	22503-72-6	Boling Point	405.1±55.0 °C at 760 mmHg
Flashing Point	198.8±31.5 °C	Density	1.4±0.1 g/cm3

IDRA-21 is a relatively new nootropic compound. It works as an ampakine stimulant drug and is currently being researched in regards to its effects in memory improvement, cognitive enhancement, stimulation, and reversing cognitive deficits. It's likely it was developed in 1994 or 1995 as the first clinical trials and peer-reviewed research articles appear in the literature in 1995.

 

Function

1. Increases in cognition
2. Increased task accuracy
3. Increases in short term memory
4. Potential therapeutic effects on schizophrenia
5. Potential therapeutic effects on depressio

Application

- Idra-21 can increases in cognition
- Idra-21 can increased task  accuracy
- Idra-21 can increases in short term memory
- Idra-21 can potential therapeutic effects on schizophrenia
- Idra-21 can potential therapeutic effects on depression
- Idra-21 can neuroprotection